3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Digestive System Disease: new trials by email Literature Review of Digestive System Disease trials Research Report on Digestive System Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Skal Pro, Placebo - Irritable Bowel Syndrome, Gastrointestinal Diseases | Phase 4 | Completed | EP Plus Group Sdn Bhd | 57 | 2024-10-17 | 2026-09-11 |
| Antidiabetic Drugs for Steatotic Liver Disease Pioglitazone, Empagliflozin, Combination of pioglitazone and empagliflozin - MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Type 2 Diabetes | Phase 4 | Completed | Yonsei University | 51 | 2018-12-06 | 2025-03-05 |
| Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Liposomal bupivacaine, Bupivacaine/epinephrine/dexamethasone - Pain, Postoperative, Crohn Disease | Phase 4 | Completed | Cedars-Sinai Medical Center | 102 | 2018-10-23 | 2021-02-17 |
Digestive System Diseases (3) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Colorectal Neoplasms (1) · Crohn Disease (1) · Diabetes Mellitus, Type 2 (1) · Disease (1) · Fatty Liver (1) · Gastrointestinal Neoplasms (1) · Inflammatory Bowel Diseases (1) · Irritable Bowel Syndrome (1) · Liver Diseases (1) · Neuralgia (1)
Pathological Conditions, Signs and Symptoms (2) · Colonic Diseases (1) · Diabetes Mellitus (1) · Digestive System Neoplasms (1) · Endocrine System Diseases (1) · Gastroenteritis (1) · Glucose Metabolism Disorders (1) · Intestinal Neoplasms (1) · Metabolic Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Diseases (1) · Nutritional and Metabolic Diseases (1)
Bupivacaine (1) · Calcium Dobesilate (1) · Pioglitazone (1) · empagliflozin (1)
Cedars-Sinai Medical Center (1) · EP Plus Group Sdn Bhd (1) · Yonsei University (1)
Malaysia (1) · South Korea (1) · United States (1)
Karen Zaghiyan, MD (1) · Yeong Yeh Lee, MD, PhD (1)